Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Pulmonary/Respiratory Diseases
Disease Category: Asthma
Trial Information
Having asthma flare-ups in spite of maintenance medication?
This study will examine the effect of Xolair on asthma exacerbations and the safety of Xolair in subjects with asthma who are not adequately controlled with ICS.
Patient Inclusion Criteria: Ages 12-75 with atopic asthma. Individuals must also have allergies to a perennial allergen such as cat or dust mite. They must have have had at least one exacerbation of asthma symptoms while on a stable ICS dose.
Patient Exclusion Criteria:
- Pregnancy or nursing
- Smoking history of greater than 10 pk yr
- Recieved Xolair in the past year
- Asprin or NSAID sensitivity.
Dana Neilson, LVN, CCRC, Study Coordinator
Allergy Asthma Research Institute
333 Londonderry Drive, Suite #110
Waco, TX 76712
Phone: 254-751-1144, option 11
Fax: 254-751-9922
EMail: dneilson@aactx.com
View Google Map
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
